Fosdenopterin Hydrobromide Patent Expiration
Fosdenopterin Hydrobromide is Used for treating Molybdenum Cofactor Deficiency Type A. It was first introduced by Sentynl Therapeutics Inc
Fosdenopterin Hydrobromide Patents
Given below is the list of patents protecting Fosdenopterin Hydrobromide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Nulibry | US7504095 | Method for obtaining precursor Z and use thereof for the production of a means for therapy of human molybdenum cofactor deficiency | Jan 31, 2025 | Sentynl Theraps Inc |
Fosdenopterin Hydrobromide's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List